Biosimilars in psoriasis: What can we expect?-Reference-Cited by-同舟云学术

Biosimilars in psoriasis: What can we expect?

Published:2014-04 Issue:4 Volume:12 Page:306-312
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Radtke Marc Alexander¹²,Augustin Matthias¹

Affiliation:

1. CVderm - Center of Excellence for Health Services Research in Dermatology, IVDP - Institute for Health Services Research in Dermatology and Nursing; University Medical Center Hamburg-Eppendorf; Hamburg Germany

2. Hamburg Dermatologie; Dermatology Practice; Hamburg Germany

Publisher

Wiley

Subject

Dermatology

Reference46 articles.

1. Deutsche Dermatologische Gesellschaft (DDG); Berufsverband Deutscher Dermatologen (BVDD). S3-Guidelines on the treatment of psoriasis vulgaris (English version). Update;Nast;J Dtsch Dermatol Ges,2012

2. Processes of psoriasis health care in Germany - long-term analysis of data from the statutory health insurances;Augustin;J Dtsch Dermatol Ges,2012

3. Development and regulation of biosimilars: current status and future challenges;Tsiftsoglou;BioDrugs,2013

4. How similar do “biosimilars” need to be?;Schellekens;Nat Biotechnol,2004

5. Clinical development of biosimilars: an evolving landscape;Subramanyam;Bioanalysis,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study;BMJ Open;2023-07

2. Adalimumab Biosimilar Efficacy and Safety in a 5-Year-Old Patient with Severe Plaque Psoriasis During SARS-CoV-2 Pandemic Outbreak;Open Access Macedonian Journal of Medical Sciences;2022-05-05

3. Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group;Expert Opinion on Biological Therapy;2021-11-16

4. Biosimilars in psoriasis: what should your positioning be?;Expert Opinion on Biological Therapy;2020-07-27